Neuroprotective effects of xenon: A therapeutic window of opportunity in rats subjected to transient cerebral ischemia

FASEB Journal

Volumn 22, Issue 4, 2008, Pages 1275-1286

  David, Hélène N ^a   Haelewyn, Benoit ^a   Rouillon, Christophe ^b   Lecoq, Myriam ^b   Chazalviel, Laurent ^b   Apiou, Gabriela ^c   Risso, Jean Jacques ^d   Lemaire, Marc ^b   Abraini, Jacques H ^a,b  

^a NNOXe Pharmaceuticals Inc   (Canada)

^b UNIVERSITÉ DE CAEN   (France)

^c AIR LIQUIDE   (France)

^d Institut de Medecine Navale du Service de Sante des Armees   (France)

Author keywords

Dopamine release; Lactate dehydrogenase; N methyl D aspartate neurotoxicity; Neurological outcome; Oxygen glucose deprivation

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; XENON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL DAMAGE; CONTROLLED STUDY; DOSE RESPONSE; EXCITOTOXICITY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DOPAMINE; ISCHEMIC ATTACK, TRANSIENT; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; XENON;

RATTUS;

EID: 42049086535     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-9420com     Document Type: Article

References (57)

1. Endres, M., and Dirnagl, U. (2002) Ischemia and stroke. Adv. Exp. Med. Biol. 513, 455-473
2. Parsons, C. G., Danysz, W., and Quack, G. (1998) Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect. 11, 523-569
3. Olney, J. W., Labruyere, J., and Price, M. T. (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362
4. Olney, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., and Sesma, M. A. (1991) NMDA antagonist neurotoxicity mechanism and prevention. Science 254, 1515-1518
5. Davis, S. M., Lees, K. R., Albers, G. W., Diener, H. C., Markabi, S., Karlsson, G., and Norris, J. (2000) Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 31, 347-354
6. Arrowsmith, J. E., Harrison, M. J., Newman, S. P., Stygall, J., Timberlake, N., and Pugsley, W. B. (1998) Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 29, 2357-2362
7. Abraini, J. H., Lemaire, M., and David, H. N. (2005) Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N. Y. Acad. Sci. 1053, 289-300
8. Cullen, S. C., Eger E. I., 2nd, Cullen, B. F., and Gregory, P. (1969) Observations on the anesthetic effect of the combination of xenon and halothane. Anesthesiology 31, 305-309
9. Yamakura, T., and Harris, R. A. (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels: comparison with isoflurane and ethanol. Anesthesiology 93, 1095-1101
10. David, H. N., Ansseau, M., Lemaire, M., and Abraini, J. H. (2006) Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. Biol. Psychiatry 60, 49-57
11. Palmer, G. C., and Widzowski, D. (2000) Low affinity use-dependent NMDA receptor antagonists show promise for clinical development. Amino Acids 19, 151-155
12. Goto, T., Suwa, K., Uezono, S., Ichinose, F., Uchiyama, M., and Morita, S. (1998) The blood-gas partition coefficient of xenon may be lower than generally accepted. Br. J. Anaesth. 80, 255-256
13. Ma, D., Wilhelm, S., Maze, M., and Franks, N. P. (2002) Neuroprotective and neurotoxic properties of the "inert" gas, xenon. Br. J. Anaesth. 89, 739-746
14. 2O enhances ketamine induced c-fos expression in the rat posterior cingulated and retrosplenial cortices. Anesth. Analg. 92, 362-368
15. Wilhelm, S., Ma, D., Maze, M., and Franks, N. P. (2002) Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 96, 1485-1491
16. Natale, G., Cattano, D., Abramo, A., Forfori, F., Fulceri, F., Fornai, F., Paparelli, A., and Giunta, F. (2006) Morphological evidence that xenon neuroprotects against N-methyl-DL-aspartic acid-induced damage in the rat arcuate nucleus: a time-dependent study. Ann. N. Y. Acad. Sci. 1074, 650-658
17. Petzelt, C., Blom, P., Schmehl, W., Muller, J., and Kox, W. J. (2003) Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci. 72, 1909-1918
18. Petzelt, C., Blom, P., Schmehl, W., Muller, J., and Kox, W. J. (2004) Xenon prevents cellular damage in differentiated PC-12 cells exposed to hypoxia. BMC Neurosci. 5, 55-63
19. Ma, D., Yang, H., Lynch, J., Franks, N. P., Maze, M., and Grocott, H. P. (2003) Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 98, 690-698
20. David, H. N., Leveillé, F., Chazalviel, L., MacKenzie, E. T., Buisson, A., Lemaire, M., and Abraini, J. H. (2003) Reduction of ischemic brain damage by nitrous oxide and xenon. J. Cereb. Blood Flow Metab. 23, 1168-1173
21. Homi, H. M., Yokoo, N., Warner, D. S., Franks, N. P., Maze, M., and Grocott, H. P. (2003) The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99, 876-881
22. Ma, D., Hossain, M., Chow, A., Arshad, M., Battson, R. M., Sanders, R. D., Mehmet, H., Edwards, A. D., Franks, N. P., and Maze, M. (2005) Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann. Neurol. 58, 182-193
23. Ma, D., Hossain, M., Pettet, G. K., Luo, Y., Lim, T., Akimov, S., Sanders, R. D., Franks, N. P., and Maze, M. (2006) Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J. Cereb. Blood Flow Metab. 26, 199-208
24. Dingley, J., Tooley, J., Porter, H., and Thoresen, M. (2006) Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 37, 501-506
25. Yao, L. P., Bandres, J., Nemoto, E. M., Boston, J. R., Darby, J. M., and Yonas, H. (1992) Effects of 33% xenon inhalation on whole-brain blood flow and metabolism in awake and fentanylanesthetized monkeys. Stroke 23, 69-74
26. Frietsch, T., Bogdanski, R., Blobner, M., Werner, C., Kuschinsky, W., and Wackle, K. F. (2001) Effects of xenon on cerebral blood flow and cerebral glucose utilization in rats. Anesthesiology 94, 290-297
27. Yao, L., Nemoto, E. M., Boston, J. R., Darby, J. M., and Yonas, H. (1992) Effect of 80% Xe on whole brain blood flow and metabolism in awake monkeys. J. Neurosurg. Anesthesiol. 4, 268-271
28. Schmidt, M., Marx, T., Kotzerke, J., Luderwald, S., Armbruster, S., Topalidis, P., Schirmer, U., and Reinelt, H. (2001) Cerebral and regional organ perfusion in pigs during xenon anaesthesia. Anaesthesia 56, 1154-1159
29. Monyer, H., Goldberg, M. P., and Choi, D. S. (1989) Glucose deprivation neuronal injury in cortical cell culture. Brain Res. 483, 347-354
30. Priestley, T., Horne, A. L., McKernan, R. M., and Kemp, J. A. (1990) The effect of NMDA receptor glycine site antagonists on hypoxia-induced neurodegeneration of rat cortical cell cultures. Brain Res. 531, 183-188
31. Deshpande, S. S., Smith, C. D., and Filbert, M. G. (1995) Assessment of primary neuronal cell culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch. Toxicol. 69, 384-390
32. Koh, J. Y., and Choi, D. W. (1987) Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 83-90
33. Paxinos, G., and Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates, Academic Press, New York
34. Konstas, A. A., Choi, J. H., and Pile-Spellman, J. (2006) Neuroprotection for ischemic stroke using hypothermia. Neurocrit. Care. 4, 168-178
35. Jevtovic-Todorovic, V., Todorovic, S. M., Mennerick, S., Powell, S., Dikranian, K., Benshoff, N., Zorumski, C. F., and Olney, J. W. (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat. Med. 4, 460-463
36. Fisher, C. M. (1998) Lacunes: small, deep cerebral infarcts: 1965. Neurology 50, 841-852
37. Ferrer, I., Martin, F., Serrano, T., Reiriz, J., Perez-Navarro, E., Alberch, J., Macaya, A., and Planas, A. M. (1995) Both apoptosis and necrosis occur following intrastriatal administration of excitotoxins. Acta Neuropathol. (Berl.) 90, 504-510
38. Kollmar, R., Blank, T., Han, J. L., Georgiadis, D., and Schawb, S. (2007) Different degrees of hypothermia after experimental stroke: short- and long-term outcome. Stroke 38, 1585-1589
39. Sobrado, M., Roda, J. M., Lopez, M. G., Egea, J., and Garcia, A. G. (2004) Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation. Neurosci. Lett. 365, 132-136
40. Zhou, M., and Baudry, M. (2006) Developmental changes in NMDA neurotoxicity reflect changes in subunit composition of N-methyl- D-aspartate (NMDA) receptors. J. Neurosci. 26, 2956-2963
41. McCarran, W. J., and Goldberg, M. P. (2007) White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. J. Neurosci. 27, 4220-4229
42. Bresink, I., Benke, T. A., Collett, V. J., Seal, A. J., Parsons, C. G., Henley, J. M., and Collingridge, G. L. (1996) Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br. J. Pharmacol. 119, 195-204
43. Parsons, C. G., Danysz, W., and Quack, G. (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38, 735-767
44. Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., and Seeburg, P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540
45. Porter, R. H., and Greenamyre, J. T. (1995) Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J. Neurochem. 64, 614-623
46. Rogawski, M. A. (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325-331
47. Goldberg, M. P., and Choi, D. W. (1993) Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13, 3510-3524
48. Gemba, T., Oshima, T., and Ninomiya, M. (1994) Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63, 789-795
49. 3H]-dopamine from rat striatal slices. Clin. Exp. Pharmacol. Physiol. 22, 301-302
50. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 65, 443-452
51. + channel involved in neuroprotection and general anesthesia. EMBO J. 23, 2684-2695
52. Dinse, A., Fohr, K. J., Georgieff, M., Beyer, C., Bulling, A., and Weigt, H. U. (2005) Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br. J. Anaesth. 94, 479-485
53. Colloc'h, N., Sopkoya-de Oliveira Santos, J., Retailleau, P., Vivares, D., Bonnete, F., Langlois d'Estainto, B., Gallois, B., Brisson, A., Risso, J. J., Lemaire, M., Prange, T., and Abraini, J. H. (2007) Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys. J. 92, 217-224
54. Goto, T., Nakata, Y., Ishiguro, Y., Niimi, Y., Suwa, K., and Morita, S. (2000) Minimum alveolar concentration-awake of xenon alone and in combination with isoflurane or sevoflurane. Anesthesiology 93, 1188-1193
55. Koblin, D., Fang, Z., Eger, E. I., 2nd, Laster, M. J., Gong, D., Ionescu, P., Halsey, M. J., and Trudell, J. R. (1998) Minimum alveolar concentrations of noble gases, nitrogen and sulfur hexafluoride in rats: helium and neon as nonimmobilizers. Anesth. Analg. 87, 419-424
56. Henninger, N., Kuppers-Tiedt, L., Sicard, K. M., Gunther, A., Schneider, D., and Schwab, S. (2006) Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Exp. Neurol. 201, 316-323
57. Haelewyn, B., Alix, P., Maubert, E., and Abraini, J. H. (2007). Time-course of NMDA-induced striatal brain damage in rats and time-dependence reliability of thionin staining. J. Neurosci. Methods. In press.